What's in Materia Medica Holding's pipeline?

Materia Medica Holding has 15 drugs in our index: 9 marketed, 0 filed, 6 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Materia Medica Holding's portfolio?

Top competitors by shared drug class: TJ Biopharma Co., Ltd., ASLAN Pharmaceuticals, Ahn-Gook Pharmaceuticals Co.,Ltd, Actavis Mid-Atlantic LLC, Active Biotech AB.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/materia-medica-holding.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Materia Medica Holding — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Materia Medica Holding pipeline: 9 marketed, 0 filed, 6 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

9 marketed 0 filed 6 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
Subetta	Subetta	marketed		Other
Tenoten for children	Tenoten for children	marketed	Homeopathic preparation	Psychiatry/Neurology
Tenoten	Tenoten	marketed		Other
Anaferon for Children	Anaferon for Children	marketed	Immunomodulator	Immunology / Virology
Anaferon	Anaferon	marketed		Other
Ergoferon	Ergoferon	marketed		Other
Rengalin	Rengalin	marketed		Other
Kolofort	Kolofort	marketed		Other
Divaza	Divaza	marketed		Other
Placebo (liquid dosage form)	Placebo (liquid dosage form)	phase 3
Dietressa	Dietressa	phase 3		Other
Afalaza	Afalaza	phase 3		Other

Therapeutic area mix

Other · 11
Immunology / Virology · 1
Oncology · 1
Psychiatry/Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

TJ Biopharma Co., Ltd. · 2 shared drug classes
ASLAN Pharmaceuticals · 1 shared drug class
Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
Actavis Mid-Atlantic LLC · 1 shared drug class
Active Biotech AB · 1 shared drug class
Addpharma Inc. · 1 shared drug class
ATGC Co., Ltd. · 1 shared drug class
ALK-Abelló A/S · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Materia Medica Holding:

Cite this brief

Drug Landscape (2026). Materia Medica Holding — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/materia-medica-holding. Accessed 2026-05-17.